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The accumulation of heparan sulfate (HS) in lysosomes
is the primary consequence of the enzyme defect (a-N-
acetylglucosaminidase) in mucopolysaccharidosis type
IIIB. This accumulation triggers a cascade of pathologi-
cal events that progressively leads to CNS pathology.
Here we examined the activation of the three major
stress kinases in the neuronal tissue of a murine model
of the disease. ERK1/2 was signiﬁcantly higher in the
cortex of 1–2-month-old affected animals compared
with wild-type (Wt) littermates. Similarly, ERK1/2 was
stimulated in neurons cultured from MPS IIIB mice.
SAPK/JNK was also found to be activated in the cortex
of 1–2-month-old affected animals compared with Wt
subjects, and the same was found for cultured neurons.
In contrast, the active form of p38MAPK was lower in the
cortex of 1-month-old MPS IIIB mice compared with Wt
animals, but no signiﬁcant difference was found between
the two p38MAPK analyzed in normal and affected neu-
rons cultured in vitro. These data indicate the possible
involvement of MAPK dysregulation in the early stage of
MPS IIIB brain disease. V V C 2011 Wiley-Liss, Inc.
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Mucopolysaccharidosis IIIB (MPS IIIB) is a lysoso-
mal storage disorder (LSD) associated with severe and
progressive neurodegeneration, which is the most promi-
nent clinical symptom (Neufeld and Muenzer, 2001) and
the most difﬁcult challenge for therapy (Cressant et al.,
2004; Zheng et al., 2004; Di Natale et al., 2005; Di
Domenico et al., 2009). As for the majority of LSDs, in
MPS IIIB the deﬁciency of a single, speciﬁc lysosomal
hydrolase (a-N-acetylglucosaminidase, NAGLU; E.C.
3.2.1.50) causes the accumulation in the patient’s cells of
its undegraded substrate, heparan sulfate (HS). The
buildup of this nondegraded substrate is believed to be
primarily responsible for the disease pathogenesis. Many
factors have been shown to contribute: an inﬂammatory
response with microglial activation followed by the
secretion of toxic cytokines (Li et al., 2002; Ohmi et al.,
2003; Villani et al., 2007), an alteration in neuroplasticity
(Li et al., 2002) and neurotrophins (Villani et al., 2007),
accumulation of immunoreactive subunit c of mitochon-
drial ATP synthase (Ryazantsev et al., 2007), degradation
of synaptophysin by the proteasome (Vitry et al., 2009),
and involvement of T-cell-mediated cytotoxicity (DiRo-
sario et al., 2009; Villani et al., 2009). However, despite
all the efforts to clarify the MPS IIIB disease pathogene-
sis, the sequence of events from the enzyme deﬁciency
to the cellular dysfunction is still obscure.
The mammalian family of mitogen-activated protein
kinases (MAPKs) includes the so-called stress kinases:
extracellular signal-regulated kinase (ERK), c-Jun NH2
terminal kinase [JNK; also known as stress-activated pro-
tein kinase (SAPK)], and p38 (Seger and Krebs, 1995;
Kim and Choi, 2010). MAPKs are activated by phospho-
rylation on speciﬁc Thr and Tyr sites by upstream kinases.
Extracellular regulated kinase 1/2 (ERK1/2) typically
regulates growth and cell proliferation and differentiation,
whereas stress-activated protein kinase/Jun kinase (JNK)
and p38MAPK are activated in response to osmotic
shock, UV irradiation, inﬂammatory cytokines, and oxi-
dative stress (Haddad and Adams, 2004). Moreover, JNK
has been associated with neuroﬁbrillary pathology (Will-
aime-Morawek et al., 2003), and its up-regulation has
been shown to overlap with phosphorylated tau (Zhu
et al., 2001). Once activated, these serine-threonine ki-
nases mediate a variety of cellular responses, including cell
proliferation, differentiation, survival, death, and transfor-
mation (McCubrey et al., 2006; Dhillon et al., 2007).
However, although it is well established that ERK activa-
tion has beneﬁcial effects on the cells, recent ﬁndings
with neural cells show that ERK may exert an opposite
effect, in that its activation can either promote neuron
survival or cause cell death. For example, in a number of
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tion of ERK is able to impair the physiological response
to neurotrophic factors and/or to drive cells to death
(Colucci-D’Amato et al., 2003). Moreover, ERK activa-
tion was suggested to play a role in a caspase-independent
mechanism of cell death involving an alteration of the
plasma membrane (Subramaniam et al., 2004).{FN0}
We found oxidative stress to be one of the main
factors implicated in MPS IIIB disease pathogenesis (Vil-
lani et al., 2007, 2009). One of the consequences of
increased reactive oxygen species (ROS) levels in the
brain of affected mice might be the activation of the
stress kinases. To test this hypothesis, the present study
analyzed the expression of phospho-ERK1/2, -SAPK/
JNK, and -p38MAPK in the cortex and embryonic neu-
rons cultured from MPS IIIB mice.
MATERIALS AND METHODS
Chemicals
Hanks’ balanced salt solution and MEM were purchased
from Gibco (Grand Island, NY). Fetal bovine serum, L-gluta-
mine, penicillin G, and streptomycin were obtained from
Cambrex. Cell Signaling Technology (Beverly, MA) supplied
the ﬁrst antibodies raised against phospho-ERK1/2 (product
No. 4370), phospho-SAPK/JNK (product No. 4668), and
phospho-p38MAPK (product No. 9211) and the goat anti-
rabbit IgG horseradish peroxidase (HRP)-conjugated second-
ary antibody (product No. 7074). Poly-D-lysine, cytosine ara-
binoside, and trypsin were purchased from Sigma (Milan,
Italy), as were the mouse anti-g-tubulin monoclonal primary
antibody (product No. T6557) and the goat anti-mouse IgG
HRP-conjugated secondary antibody.
Animals
The mice were genotyped by PCR performed on DNA
samples extracted from tail biopsy at 1 month after birth, as
previously described (Di Natale et al., 2005). For the study on
adult mouse cortices, homozygous mutant mice and wild-type
(Wt) control mice of 1, 2, 3, and 6 months of age were used.
At the time of killing, the mice were sacriﬁced by cervical dis-
location after profound anesthesia. The cerebrum was rapidly
removed, and the cortex isolated by using a stereomicroscope
(Zeiss) on an ice-cold tissue culture plate. The cortices were
then transferred to microcentrifuge tubes and immediately
stored at –808C until use. For the preparation of primary neu-
ronal cultures, timed pregnancies of MPS IIIB and Wt mice
were set up, and embryos were obtained by cesarean section of
pregnant mice 16 days postcoitum. All experimental protocols
were approved by the Italian Ministry of Public Health.
Western Blotting
Brain cortices were homogenized on ice in lysis buffer
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM Na2EDTA,
1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1
mM b-glycerophosphate, 1 mM Na3VO4) supplemented with
protease inhibitors (1 lg/ml leupeptin, 1 lg/ml aprotinin, 1
mM PMSF) and incubated for 30 min on ice. After centrifuga-
tion at 14,000 rpm at 48C for 30 min, the supernatants were
used for protein determination by the Bradford method
(Bradford, 1976) with BSA as a standard. The same protocol
was used for the preparation of total protein extract from neuro-
nal cells. Western blotting analysis was carried out on equal
amounts of protein extracts. Brieﬂy, 30 lg of total protein
extract was boiled for 5 min in SDS/reducing loading buffer,
run on a 10% SDS-PAGE, and then transferred onto nitrocellu-
lose membranes (Millipore, Bedford, MA). The membranes
were blocked for 1 hr at room temperature with 5% BSA (or
5% skim-milk powder for anti-g-tubulin) in T-TBS (30 mM
Tris-HCl, 125 mM NaCl, 0.1% Tween 20). The blots were
then incubated overnight at 48C with the speciﬁc primary anti-
body, appropriately diluted in T-TBS containing 5% BSA for
the phospho-MAPK antibodies or 2% milk for the tubulin anti-
body. The primary antibodies used were rabbit antiphospho-
ERK1/2 (1:1,000), rabbit antiphospho-SAPK/JNK (1:500),
rabbit antiphospho-p38MAPK (1:500), and mouse anti-g-tubulin
(1:10,000). After washing in T-TBS (30 mM Tris-HCl, 125
mM NaCl, 0.05% Tween 20), the membranes were incubated
for 1 hr at room temperature with goat anti-rabbit or anti-
mouse HRP-conjugated secondary antibody diluted in T-TBS
containing 2% milk (1:3,000). The proteins were visualized by
an enhanced chemiluminescence reaction using ECL detection
reagent (Amersham, Arlington Heights, IL), followed by expo-
sure to Fuji ﬁlm. The same blots were stripped and reprobed
with g-tubulin monoclonal antibody to conﬁrm equal loading
of proteins in all lanes. Films were scanned using an HP scanner
and subjected to densitometric analysis in ImageJ software.
Primary Cortical Neuronal Cultures
Neuronal cultures were prepared from embryonic day
16 (E16) mouse cortices as described by Scorziello and col-
leagues (2001), with some modiﬁcations. Brains of mouse
embryos, obtained from time-pregnant MPS IIIB and Wt
mice, were collected and placed in ice-cold Hanks’ balanced
salt solution supplemented with 5 mg/ml glucose, 7 mg/ml
saccharose, and 0.3 mg/ml sodium bicarbonate. Cortices were
then isolated under a stereomicroscope by removing the
attached meninges and incubated with 0.25% trypsin for 20
min at 378C. After centrifugation at 600g for 5 min, the cells
were dissociated by careful titration through a constricted Pas-
teur pipette. Dissociated neurons were resuspended in minimal
essential medium (MEM) containing glucose, 5% heat-inacti-
vated fetal bovine serum, 5% heat-inactivated horse serum, 2
mM L-glutamine, and 100 U/ml and 100 lg/ml of a mixture
of penicilin-streptomycin and seeded at a density of 2 3 10
6
cells on 35-mm Petri dishes precoated overnight with 0.1
mg/ml poly-D-lysine. After 24 hr, the medium was replaced
with freshly prepared medium of similar composition, and
neuronal cells were maintained in a humidiﬁed 5% CO2/95%
air atmosphere at 378C until use. Cytosine-D-arabino-furano-
side (10 lM) was added at 5 days in vitro (DIV) to prevent
glial proliferation, and experiments were performed on cul-
tures at 8 DIV. The purity of the cultures was veriﬁed to be
95% using the neuron-speciﬁc marker microtubule-associated
protein-2 (MAP2) and the astrocyte marker glial ﬁbrillary
acidic protein (GFAP). The data from each experiment were
obtained from at least three individual culture preparations
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each experiment was repeated at least three times.
Measure of HS Levels in Cultured Neurons
The level of HS in embryonic neurons cultured from
MPS IIIB and Wt animals was measured according to .sson
(1993), with some modiﬁcations. Brieﬂy, the total extract
from neuron pellets (300 lg) was resuspended in 0.9% NaCl/
0.2% Triton X-100, rotated at 48C overnight, and centrifuged
to remove debris. GAGs were precipitated with Alcian blue,
and absorbance was measured at 600 nm. HS from porcine in-
testinal mucosa was used as a standard.
Statistical Analysis
All results are presented as histograms, and data are
expressed as means and SD of ﬁve independent experiments.
Student’s t-test was used to assess whether there were signiﬁ-
cant differences between MPS IIIB and control mice.
RESULTS
Our work was aimed at the dissection of the intra-
cellular pathways that might be switched on/off in the
cortex and in cultured neurons of MPS IIIB mice. Three
major protein kinase pathways have been shown to be
responsive to insults such as stress, ERK1/2, JNK, and
p38MAPK. Therefore, we examined by Western blot
the level of the three MAPKs by using antibodies spe-
ciﬁc for each phosphorylated form of these enzymes.
ERK and JNK Activation Is Increased in the
Cortex of MPS IIIB Mice
We evaluated the activation status of ERK1/2 in
the cortex of MPS IIIB and Wt mice by Western blot
on the homogenates of cortex derived from mice at dif-
ferent ages. We used a primary monoclonal antibody
raised against phospho-(Thr202/Tyr204)-ERK, selective
for the two isoforms of the enzyme, corresponding to
phospho-ERK1 and phospho-ERK2, with apparent mo-
lecular weights of 44 kDa and 42 kDa, respectively. We
found that both p44 and p42 were signiﬁcantly activated
in 1–2-month-old MPS IIIB mice, as shown in Figure
1. The quantitative analysis performed comparing the
density of the corresponding bands with that of tubulin
is shown in Figure 1B,C, respectively. The levels of
Fig. 1. ERK is activated in the cortex of 1-month-old MPS IIIB
mice. Activation of ERK was visualized using speciﬁc antibody for
its phosphorylated form. A: Representative Western blot analysis of
phospho-ERK1/2 (p44/p42) on homogenates of the cortex of Wt
and MPS IIIB mice. Western blot analysis of tubulin, performed on
the same gel, is shown for comparison. ERK phosphorylation was
quantitated after scanning as ratio between p-ERK1 and tubulin (B)
and between p-ERK2 and tubulin (C). Each band density was calcu-
lated separately. The histogram shows the mean 6 SD of ﬁve inde-
pendent experiments. The levels of phospho-p44 and phospho-p42
in 1–2-month-old MPS IIIB mice were signiﬁcantly higher than in
Wt (*1-month-old P < 0.005; *2-month-old P < 0.1, Student’s t-
test). Open bars, Wt mice, n 5 5; solid bars, affected mice, n 5 5.
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were twofold higher than in Wt littermates (Fig. 1, open
bars), and the increase was statistically signiﬁcant. Selec-
tive up-regulation of ERK1/2 was lost with older mice
(3 and 6 months).
The activation status of SAPK/JNK was evaluated
by Western blot using a polyclonal antibody raised
against phospho-(Thr183/Tyr185)-SAPK-JNK, showing
only two major bands at apparent molecular weights of
54 kDa and 46 kDa. Figure 2A indicates that SAPK-
JNK is activated in the ﬁrst 2 months from birth of
MPS IIIB mice compared with Wt controls. The quan-
titative analyses performed comparing the density of the
corresponding bands with that of tubulin are illustrated
in Figure 2B,C, respectively. A signiﬁcant increase was
evident only at 1–2 months of age. As for pERK1/2,
the selective up-regulation of JNK decreased with age.
Down-Regulation of p38MAPK in the
Cortex of MPS IIIB Mice
To evaluate the activation status of p38MAPK, a
Western blot was performed using an antiphospho-
p38MAPK antibody raised against phospho-(Thr180/
Tyr182)-p38MAPK, showing a single major band at an
apparent molecular weight of 38 kDa. Figure 3A shows
a representative Western blot demonstrating that p38 is
present in the cortex of MPS IIIB mice but is less than
that found in the cortex of Wt mice. A quantitative
analysis of the data found in Wt (Fig. 3, open bars) and
MPS IIIB (Fig. 3, solid bars), performed by comparison
with the tubulin band, is shown in Figure 3B. The data
show that p38MAPK is less phosphorylated in the cortex
of MPS IIIB mice at each time considered from birth,
although the difference is statistically signiﬁcant only at 1
month of age.
Fig. 2. Activation of SAPK/JNK in the cortex of 2-month-old MPS
IIIB mice. Activation of SAPK/JNK was visualized using speciﬁc
antibody for its phosphorylated form. A: Representative Western
blot analysis of phospho-SAPK/JNK (p54/p46) on homogenates of
the cortex of Wt and MPS IIIB mice; Western blot analysis of tubu-
lin, performed on the same gel, is shown for comparison. B,C:
Quantitative analysis of activated SAPK/JNK performed comparing
the immunopositive band of phospho-p54 (B) or phospho-p46 (C)
with that of tubulin run on the same gel; each band density was cal-
culated separately. The histogram values shows the mean 6 SD of
ﬁve independent experiments. The levels of phospho-p46 in 1–2-
month-old MPS IIIB mice were signiﬁcantly higher than in Wt (*1-
month-old P < 0.1; *2-month-old P < 0.05, Student’s t-test); Open
bars, Wt mice, n 5 5; solid bars, affected mice, n 5 5.
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Neurons were isolated from the cortex of Wt and
MPS IIIB mice at embryonic day 16. The levels of HS
were signiﬁcantly higher (P < 0.005, Student’s t-test) in
cells from affected mice (8.3 6 1.1 lg GAGs/mg pro-
tein) with respect to those found in Wt controls (2.8 6
0.65 lg GAGs/mg protein).
Phosphorylation Status of MAPKs in Cultured
Neurons From MPS IIIB Mice
To evaluate whether the alterations in the MAPK
pathway identiﬁed in the cortex of MPS IIIB mice are
present already at an early stage of cortex development,
we analyzed the phosphorylation status of MAPKs in
neurons cultured from MPS IIIB and Wt mice. The
activation of MAPKs in cultured neurons was analyzed
by Western blotting on protein extract obtained from
MPS IIIB and Wt cortical neurons at 8 DIV. Both ERK
and SAPK/JNK showed an increase in the phosphoryl-
ated bands in MPS IIIB neurons (Fig. 4A,C). A quanti-
tative analysis performed comparing the immunopositive
bands of each kinases with that of tubulin reveals that
the differences between MPS IIIB (Fig. 4, solid bars)
and Wt (Fig. 4, open bars) are statistically signiﬁcant
(Fig. 4B,D). Increased phosphorylation of the p38MAPK
band seems to be present in MPS IIIB cultured neurons
(Fig. 4E), but no statistical signiﬁcance was shown by
quantitative analysis (Fig. 4F).
DISCUSSION
In the present work, we studied the activation of
the three main stress kinases (MAPK) in an MPS IIIB
mouse model and showed that a selective activation of
MAPK is involved in the disease pathogenesis. Our data
show an increased activation of ERK and SAPK/JNK in
the ﬁrst 2 months after birth in the cortex of MPS IIIB
animals. Although the increased ERK and SAPK/JNK
expression was detected in the cortex, at present we can-
Fig. 3. Down-regulation of p38MAPK in the cortex of 1-month-old
MPS IIIB mice. Activation of p38MAPK was visualized using spe-
ciﬁc antibody for its phosphorylated form. A: Representative West-
ern blot analysis of phospho-p38MAPK on homogenates of the cor-
tex of Wt and MPS IIIB mice. Western blot analysis of tubulin, per-
formed on the same gel, is shown for comparison. B: Quantitative
analysis of activated p38MAPK performed comparing the immuno-
positive band of phospho-p38MAPK with that of tubulin run on the
same gel. The histogram shows the mean 6 SD of ﬁve independent
experiments. The levels of phospho-p38MAPK in 1-month-old MPS
IIIB mice were signiﬁcantly lower than in Wt (*P < 0.05, Student’s
t-test). Open bars, Wt mice, n 5 5; solid bars, affected mice, n 5 5.
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mice. Phosphorylation status of MAPKs ERK1/2, SAPK/JNK, and
p38MAPK were visualized using speciﬁc antibody for their phospho-
rylated form on cellular extracts obtained from cortical neurons of
MPS IIIB and Wt mice at 8 days in vitro. A,C,E: Representative
Western blot analysis of phospho-ERK1/2 (A), SAPK/JNK (C), and
p38MAPK (E); Western blot analysis of tubulin performed on the
same gel is shown for comparison. B,D,F: Quantitative analysis of
activated kinases performed comparing the immunopositive band of
phospho-ERK1/2 (B), SAPK/JNK (D), and p38MAPK (F) with that
of tubulin run on the same gel; each band density was calculated sep-
arately. The histogram shows the mean 6 SD of ﬁve independent
experiments.The levels of phospho-p44 and phospho-p42 in cultured
neurons from MPS IIIB mice were signiﬁcantly higher than in Wt
(p44 *P < 0.1 and p42 *P < 0.05, Student’s t-test); the levels of
phospho-p54 and phospho-p46 (*P < 0.1, Student’s t-test) were also
higher. No signiﬁcant differences were observed for p38 kinase.
Open bars, Wt mice, n 5 5; solid bars, affected mice, n 5 5.
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cortical area. Our results are in agreement with the ﬁnd-
ings of early activation of ERK in some neurodegenera-
tive diseases: phosphorylated ERK immunoreactivity has
been found in neurons in Pick’s disease and progressive
supranuclear palsy and corticobasal degeneration (Ferrer
et al., 2001), in hippocampal neurons with neuroﬁbrillar
degeneration in Alzheimer’s disease (AD; Perry et al.,
1999), and in astrocytes from early AD patients (Webster
et al., 2006). In all these cases, ERK activation was not
maintained with disease progression.
The alterations in the CNS in MPS IIIB shared
some features with other neurodegenerative diseases,
especially Alzheimer’s disease (AD), such as the accumu-
lation of abnormal products, activation of microglia, and
alteration of the lysosomal and autophagic degradation
pathway. In this regard, it is interesting to note that
Ohmi and coworkers (2009) recently described for the
ﬁrst time the presence of a hyperphosphorylated form of
microtubule-associated protein tau in the brain of MPS
IIIB mice, a characteristic of many storage diseases asso-
ciated with dementia. An accumulation of HS is the pri-
mary consequence of the enzyme defect in MPS IIIB
and triggers a cascade of pathological events that progres-
sively leads to CNS pathology. Ausseil and coworkers
(2008) detected GAG accumulation in the brain of MPS
IIIB mice already at the age of 10 days, but we observed
the HS accumulation in neuron cultures from the brain
of E16 MPS IIIB mice. It has been demonstrated that
heparin is able to promote tau aggregation in vitro, so it
is likely that this function is carried out by HS in vivo
(Pandel and Li, 1999). This observation could suggest
that HS accumulation in the early stage of MPS IIIB dis-
ease could promote tau aggregation and consequent
hyperphosphorylation through the activation of MAPK,
as demonstrated in other models of neurodegeneration
(Perez et al., 2008). Alternatively, early activation of
ERK and SAPK/JNK may represent a ﬁrst response to
the onset of MPS IIIB pathology and thus may be linked
to neuroprotective pathways. In fact, as discussed above,
different kinetics of ERK activation can account for its
dual effects, i.e., survival or death of neuronal cells
(Colucci-D’Amato et al., 2003). Interestingly, the rises
in pERK and pSAPK/JNK immunoreactivity were tran-
sient and more characteristic of the early stage of disease
and, therefore, may be a reaction to ongoing neuronal
damage. Thus, the increase in ERK and SAPK/JNK
phosphorylation may be a reaction to microglia activa-
tion caused by HS, a feature that Ausseil and coworkers
(2008) identiﬁed in the early stage of MPS IIIB brain
pathology.
Our results from the cortex of MPS IIIB mice
were conﬁrmed by the study of embryonic cultured
cortical neurons, in which the patterns of ERK and
SAPK/JNK phosphorylation reﬂect those observed in
the brain of postnatal mice and permit us to speculate
that this activation is present already during fetal life.
Moreover, our data obtained from pure neuronal cul-
tures, devoid of astrocytes and microglia, allow us rea-
sonably to assume that this phenomenon is not second-
ary to the activation of microglia, and this is in agree-
ment with the assumption of Ausseil and coworkers
(2008) that, in the early stage of MPS IIIB disease, the
pathology of the CNS is cell autonomous rather than
environmental.
We found that p38MAPK was down-regulated in
the cortex of MPS IIIB mice compared with Wt litter-
mates. Increased activation of p38MAPK has been found
in brain homogenates in all the tauopathies (Ferrer et al.,
2005), and often phosphorylated p38MAPK immunore-
activity has been found in colocalization with activated
SAPK/JNK (Ferrer et al., 2001; Giovannini et al.,
2008). It is widely accepted that the activation of
p38MAPK is related to the production of proinﬂamma-
tory cytokines but also to an aggravation of the inﬂam-
matory processes, a feature shared by most chronic neu-
rodegenerative diseases. The inhibition of p38MAPK
phosphorylation could support the hypothesis that early
activation of ERK and SAPK/JNK represents a ﬁrst
response to the onset of the pathology.
In conclusion, these experiments show that a dys-
regulation of MAPK is present in the murine model of
MPS IIIB. In particular, the early stages of the disease
are characterized by simultaneous activation of ERK and
SAPK/JNK pathways and inhibition of p38MAPK phos-
phorylation. These results together with our ﬁndings
from pure neuronal cultures allow us to suggest not only
that the alteration of the MAPK pathways is involved in
the pathophysiological changes that occur early on in the
brain of MPS IIIB mice but also that these events are
cell autonomous and not dependent on environmental
alterations, at least in the early stages of brain disease.
We propose that, in the early pathological mecha-
nisms involved in MPS IIIB disease, a dysregulation of
stress kinases could be included in the pathogenetic cas-
cade following enzymatic deﬁcit. It could well be, in
fact, that an increased ROS production (Villani et al.,
2007, 2009) might lead to the activation of ERK1/2
and SAPK/JNK and to the inhibition of p38MAPK (this
work). However, whether this leads to cell death, as
suggested for other lysosomal diseases (for review see
Walkley, 2009), remains to be demonstrated for MPS
IIIB. In this regard, previous data on apoptotic or nona-
poptotic mechanisms in brain disease of MPS IIIB are
controversial (Li et al., 2002; Villani et al., 2007, 2009).
Finally, although further studies are required to deﬁne
the exact sequence of pathological events in MPS IIIB
brain disease, our work, to our knowledge, is the ﬁrst
study reporting that cell signaling transduction alterations
are involved in the MPS IIIB neuronal pathology.
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